# EDGAR Filing Document

**Accession Number:** 0001855886
**File Stem:** 0001104659-23-029550
**Filing Date:** 2023-3
**Character Count:** 15603
**Document Hash:** c5e26890a65f3d3cef4c44c43d9f742e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-029550.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001104659-23-029550

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230303

**ITEM INFORMATION**: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

**ITEM INFORMATION**: Material Modifications to Rights of Security Holders

**ITEM INFORMATION**: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230307

**DATE AS OF CHANGE**: 20230307

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Arbor Rapha Capital Bioholdings Corp. I
- **CENTRAL INDEX KEY:** 0001855886
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 862427174
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40967
- **FILM NUMBER:** 23712721

**BUSINESS ADDRESS:**
- **STREET 1:** 333 EARLE OVINGTON BLVD., SUITE 900
- **CITY:** UNIONDALE
- **STATE:** NY
- **ZIP:** 11553
- **BUSINESS PHONE:** (516) 506-4200

**MAIL ADDRESS:**
- **STREET 1:** 333 EARLE OVINGTON BLVD., SUITE 900
- **CITY:** UNIONDALE
- **STATE:** NY
- **ZIP:** 11553

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): March 3, 2023**

**Arbor Rapha Capital Bioholdings Corp. I**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-40967** | **82-2427174** |
| **(State or other jurisdiction**<br> **of incorporation)**<br>| **(Commission <br> File Number)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **333 Earle Ovington Blvd. Suite 900 Uniondale, NY** | **11553** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**(516) 506-4200**

**(Registrant's telephone number, including area code)**

**Not Applicable** 

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br> **Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| **Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant** | **N/A** |  |
| **Class A common stock, par value $0.0001 per share** | **N/A** |  |
| **Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50** | **N/A** |  |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp; ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

---

| | |
|:---|:---|
| **Item 3.01** | **Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.** |

---

On March 3, 2023, Arbor Rapha Capital Bioholdings Corp. I, a Delaware corporation (the "Company", "we" or "our") held a special meeting of stockholders (the "Special Meeting") at which the Company's stockholders approved certain amendments to the Company's Amended and Restated Certificate of Incorporation (the "Certificate of Incorporation"). In connection therewith, the Company gave formal notice to Nasdaq on March 3, 2023 of its intention to dissolve and liquidate and requested that Nasdaq file a Form 25 with the U.S. Securities and Exchange Commission to delist the Company's securities. Nasdaq filed the Form 25 on March 3, 2023.

---

| | |
|:---|:---|
| **Item 3.03** | **Material Modification to Rights of Security Holders.** |

---

The information disclosed in Item 5.07 of this Current Report on Form 8-K under the heading "Proposal 1" is incorporated by reference into this Item 3.03 to the extent required herein.

---

| | |
|:---|:---|
| **Item 5.03** | **Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.** |

---

The information disclosed in Item 5.07 of this Current Report on Form 8-K under the heading "Proposal 1" is incorporated by reference into this Item 5.03 to the extent required herein.

---

| | |
|:---|:---|
| **Item 5.07** | **Submission of Matters to a Vote of Security Holders.** |

---

***Special Meeting***

On March 3, 2023, the Company, held the Special Meeting in person, at which holders of 4,344,530 ordinary shares, comprised of 32,030 shares of Class A common stock, par value $0.0001 per share, of the Company ("Class A Common Stock"), and 4,312,500 shares of Class B common stock, par value $0.0001 per share, of the Company ("Class B Common Stock", collectively with the Class A Common Stock, the "Common Stock"), were present in person or by proxy, representing approximately 99.33% of the voting power of the 4,373,832 issued and outstanding shares of the Company's Common Stock, comprised of (i) 61,332 shares of Class A Common Stock and (ii) 4,312,500 shares of Class B Common Stock, entitled to vote at the Special Meeting at the close of business on February 8, 2023, which was the record date (the "Record Date") for the Special Meeting. The Company's stockholders of record as of the close of business on the Record Date are referred to herein as "Stockholders."

**Proposal 1**

The Stockholders approved, by special resolution, the proposal to amend the Company's Certificate of Incorporation to change the date by which the Company must either (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the Company with one or more businesses, which we refer to as our "initial Business Combination", or (ii) cease all operations, except for the purpose of winding up, if it fails to complete such initial Business Combination, and redeem all of the Company's shares of Class A Common Stock, included as part of the units sold in the Company's initial public offering that was consummated on November 2, 2021, (the "IPO"), whether such shares were purchased in the IPO or in the secondary market following the IPO (including shares sold pursuant to the underwriters' over-allotment option), from August 2, 2023 to March 7, 2023 (the "Liquidation Amendment"). The voting results for such proposal were as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| For | For | Against | Against | Abstain | Abstain | Broker Non-Votes | Broker Non-Votes |
|  | 4344509 |  | 21 |  | 0 |  | 0 |

---

On March 7, 2023, to effectuate the Liquidation Amendment, the board of directors of the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company (the "Charter Amendment"). The foregoing description of the Charter Amendment does not purport to be complete and is qualified in its entirety by the terms of the Charter Amendment, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.

**Proposal 2**

The proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there were insufficient votes for, or otherwise in connection with, the Liquidation Amendment, was not presented at the Special Meeting, as the Liquidation Amendment received a sufficient number of votes required for approval.

---

| | |
|:---|:---|
| **Item 8.01** | **Other Events.** |

---

Stockholders elected to redeem an aggregate of 4,233 shares of Class A Common Stock, representing approximately 6.9% of the issued and outstanding Class A Common Stock.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp; Exhibits.

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description</u> |
| [3.1](tm238706d1_ex3-1.htm) | [Certificate of Amendment of Amended and Restated Certificate of Incorporation](tm238706d1_ex3-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Arbor Rapha Capital Bioholdings Corp. I** | **Arbor Rapha Capital Bioholdings Corp. I** |
| Date: March 7, 2023 | By: | /s/ Ivan Kaufman |
|  | Name: | Ivan Kaufman |
|  | Title: | Chief Executive Officer |

---

## Exhibit 3.1

**Exhibit 3.1**

**CERTIFICATE OF AMENDMENT**

**TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION**

**OF**

**ARBOR RAPHA CAPITAL BIOHOLDINGS CORP. I**

March 7, 2023

Arbor Rapha Capital Bioholdings Corp. I., a corporation organized and existing under the laws of the State of Delaware (the "Corporation"), hereby certifies as follows:

FIRST: Article IX, Section 9.1(b) is hereby amended and restated in its entirety to read as follows:

"(b) Immediately after the Offering, a certain amount of the net offering proceeds received by the Corporation in the Offering (including the proceeds of any exercise of the underwriters' over-allotment option) and certain other amounts specified in the Corporation's registration statement on Form S-1, as initially filed with the Securities and Exchange Commission (the "***SEC***") on September 14, 2021, as amended (the "***Registration Statement***"), shall be deposited in a trust account (the "***Trust Account***"), established for the benefit of the Public Stockholders (as defined below) pursuant to a trust agreement described in the Registration Statement. Except for the withdrawal of interest to pay taxes, none of the funds held in the Trust Account (including the interest earned on the funds held in the Trust Account) will be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of 100% of the Offering Shares (as defined below) if the Corporation is unable to complete its initial Business Combination by March 7, 2023 and (iii) the redemption of Offering Shares in connection with a vote seeking to amend any provisions of this Amended and Restated Certificate (A) to modify the substance or timing of the Corporation's obligation to allow redemptions in connection with the Corporation's initial Business Combination or to redeem 100% of the Offering Shares if the Corporation has not consummated an initial Business Combination by March 7, 2023 or (B) relating to stockholders' rights or pre-initial Business Combination activity (as described in <u>Section 9.7</u>). Holders of shares of the Corporation's Common Stock included as part of the units sold in the Offering (the "***Offering Shares***") (whether such Offering Shares were purchased in the Offering or in the secondary market following the Offering and whether or not such holders are Arbor Rapha Capital LLC (the "***Sponsor***") or officers or directors of the Corporation, or affiliates of any of the foregoing) are referred to herein as "***Public Stockholders***."

SECOND: Article IX, Section 9.2(d) is hereby amended and restated in its entirety to read as follows:

"(d) In the event that the Corporation has not consummated an initial Business Combination by March 7, 2023, the Corporation shall (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the Offering Shares in consideration of a per-share price, payable in cash, equal to the quotient obtained by dividing (A) the aggregate amount then on deposit in the Trust Account, including interest (net of taxes payable, and less up to $100,000 of such net interest to pay dissolution expenses), by (B) the total number of then outstanding Offering Shares, which redemption will completely extinguish rights of the Public Stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable law, dissolve and liquidate, subject in each case to the Corporation's obligations under the DGCL to provide for claims of creditors and other requirements of applicable law."

THIRD: Article IX, Section 9.7 is hereby amended and restated in its entirety to read as follows:

"Section 9.7 <u>Additional Redemption Rights</u>. If, in accordance with <u>Section 9.1(a)</u>, any amendment is made to this Amended and Restated Certificate that would modify the substance or timing of the Corporation's obligation to allow redemptions in connection with the Corporation's initial Business Combination or to redeem 100% of the Offering Shares if the Corporation has not consummated an initial Business Combination by March 7, 2023, or with respect to any other provision herein relating to stockholder's rights or pre- initial Business Combination activity, the Public Stockholders shall be provided with the opportunity to redeem their Offering Shares upon the approval of any such amendment, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (net of taxes payable), divided by the number of then outstanding Offering Shares."

FOURTH: This amendment to the Amended and Restated Certificate of Incorporation of the Company was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware and by affirmative vote of the number of stockholders required to vote thereon.

**IN WITNESS WHEREOF**, Arbor Rapha Capital Bioholdings Corp. I has caused this Amendment to be duly executed in its name and on its behalf by an authorized officer as of the first date set forth above.

---

| | |
|:---|:---|
| **ARBOR RAPHA CAPITAL** | **ARBOR RAPHA CAPITAL** |
| **BIOHOLDINGS CORP. I** | **BIOHOLDINGS CORP. I** |
| By: | /s/ Ivan Kaufman |
|  | Name:Ivan Kaufman |
|  | Title:Chief Executive Officer |

---